The DOI matches its Crossref record.
THE EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THREE AUSTRALIAN CITIES: PERTH, NEWCASTLE AND HOBART
Abstract
An epidemiological survey of multiple sclerosis (MS) in three Australian cities, Perth, Newcastle and Hobart, was undertaken with its prevalence day being the national census day on June 30, 1981, exactly twenty years after a previous survey of the same cities. The relationship between increasing prevalence and increasing south latitude found in the 1961 survey was confirmed in this present study. Prevalence rates had increased significantly over the twenty years between the studies. Over the same time period incidence rates had also increased in Newcastle and Hobart but had remained essentially stable in Perth although these changes were not significant. The rise in prevalence was due to a combination of factors of differing importance in each city. These factors included better case ascertainment, increased recognition of the less severely disabled patient, increased survival time and differential immigration of a population at a higher risk of developing MS than the indigenous population. Finally, analysis of MS prevalence rates amongst migrant populations in Perth and Hobart suggested that either the risk of acquisition of MS may extend over a wider age range than is generally accepted or that environmental factors prevalent in the former city have modified disease expression there.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Simpson, S., Blizzard, L., Otahal, P., Van der Mei, I., & Taylor, B. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.240432 · Cited by 718
Temporal trends in the incidence of multiple sclerosis: A systematic review
Alonso, A., & Hernán, M. A. (2008) · Neurology · doi:10.1212/01.wnl.0000316802.35974.34 · Cited by 694
A full genome search in multiple sclerosis
Ebers, G. C., Kukay, K., Bulman, D. E., Sadovnick, A. D., Rice, G., Anderson, C., Armstrong, H., Cousin, K., Bell, R. B., Hader, W., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-472 · Cited by 659
The prevalence of multiple sclerosis in the world: an update
Rosati, G. (2001) · Neurological Sciences · doi:10.1007/s100720170011 · Cited by 656
Environmental factors and multiple sclerosis
Ebers, G. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70042-5 · Cited by 629
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
van der Mei, I. A. F., Ponsonby, A.-L., Dwyer, T., Blizzard, L., Simmons, R., Taylor, B. V., Butzkueven, H., & Kilpatrick, T. (2003) · BMJ · doi:10.1136/bmj.327.7410.316 · Cited by 551
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70094-6 · Cited by 548
Major depression in multiple sclerosis: A population-based perspective
Patten, S. B., Beck, C. A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095964.34294.b4 · Cited by 529
Ramagopalan, S. V., Maugeri, N. J., Handunnetthi, L., Lincoln, M. R., Orton, S.-M., Dyment, D. A., DeLuca, G. C., Herrera, B. M., Chao, M. J., Sadovnick, A. D., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000369 · Cited by 519
The epidemiology of multiple sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 514
Epidemiologic evidence for multiple sclerosis as an infection
Kurtzke, J. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.382 · Cited by 472
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H., Dwyer, T., Gies, P., & van der Mei, I. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 457
Multiple sclerosis in the Japanese population
Kira, J.-I. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00308-9 · Cited by 419
Prevalence of chronic fatigue syndrome in an Australian population
Lloyd, A. R., Hickie, I., Boughton, C. R., Wakefield, D., & Spencer, O. (1990) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb126191.x · Cited by 389
Evidence for genetic basis of multiple sclerosis
Sadovnick, A. D., the Canadian Collaborative Study Group, Dyment, D. A., Ebers, G. C., & Risch, N. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90807-7 · Cited by 351
Vitamin D as an immune modulator in multiple sclerosis, a review
Smolders, J., Damoiseaux, J., Menheere, P., & Hupperts, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.014 · Cited by 317
Epidemiology of Multiple Sclerosis: A Critical Overview
Sadovnick, A. D., & Ebers, G. C. (1993) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100047351 · Cited by 304
Migrant studies in multiple sclerosis
Gale, C. R., & Martyn, C. N. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)80008-v · Cited by 289
Multidisciplinary rehabilitation for adults with multiple sclerosis
Khan, F., Turner-Stokes, L., Ng, L., Kilpatrick, T., & Amatya, B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006036.pub2 · Cited by 286
Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study
Andersen, O., Lygner, P.-E., Bergstr�m, T., Andersson, M., & Vablne, A. (1993) · Journal of Neurology · doi:10.1007/bf00867354 · Cited by 265
Wallin, M. T., Page, W. F., & Kurtzke, J. F. (2004) · Annals of Neurology · doi:10.1002/ana.10788 · Cited by 224
Genetics of multiple sclerosis [published erratum appears in Hum Mol Genet 1997 Nov;6(12):2189]
Dyment, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1693 · Cited by 152
Zivadinov, R., Iona, L., Monti-Bragadin, L., Bosco, A., Jurjevic, A., Taus, C., Cazzato, G., & Zorzon, M. (2003) · Neuroepidemiology · doi:10.1159/000067107 · Cited by 102
Khan, F., & Pallant, J. (2007) · The Journal of Pain · doi:10.1016/j.jpain.2007.03.005 · Cited by 78
Non-pharmacological interventions for chronic pain in multiple sclerosis
Amatya, B., Young, J., & Khan, F. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012622.pub2 · Cited by 78
Metadata
- Authors
- HAMMOND, S. R., MCLEOD, J. G., MILLINGEN, K. S., STEWART-WYNNE, E. G., ENGLISH, D., HOLLAND, J. T., & MCCALL, M. G.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1988
- Volume
- 111
- Issue
- 1
- Pages
- 1-25
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2013432990
- Cited by
- 211
- References
- 0
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.